Medical specialists from France tagged as investigators in clinical trials studying Ganglioneuroblastoma
Total 27 results
-
Anne-Sophie DEFACHELLES, MDSeen in:
- Lille, Centre Oscar Lambret
Trials:- NCT05192980 (Principal Investigator)
Conditions: -
Antoine Gourmel, MDSeen in:
- Amiens, CHU Amiens
- Somme, Amiens, CHU AMIENS-PICARDIE - Hôpital Nord
Trials:- NCT02265770 (Principal Investigator)
- NCT05192980 (Principal Investigator)
Conditions: -
Arnaud PETIT, MDSeen in:
- Paris, Hôpital Armand Trousseau
Trials:- NCT05192980 (Principal Investigator)
Conditions: -
Aude MARIE CARDINE, MDSeen in:
- Rouen, Hopital Charles Nicolle
Trials:- NCT05192980 (Principal Investigator)
Conditions: -
Benoît DUMONT, MDSeen in:
- Lyon, Centre Léon Bérard
- Lyon, LYON Centre Léon Bérard
Trials:- NCT04681417 (Principal Investigator)
- NCT05192980 (Principal Investigator)
- NCT05384821 (Principal Investigator)
- NCT02870907 (Principal Investigator)
Conditions: -
Carole COZE, MDSeen in:
- Marseille, Hopital d'Enfants de la Timone
- Marseille, Hopital d'Enfants la Timone
- Marseille, Marseille Chu
Trials:- NCT04681417 (Principal Investigator)
- NCT05192980 (Principal Investigator)
- NCT02870907 (Principal Investigator)
Conditions: -
Cécile PERRET, MDSeen in:
- Grenoble, Chu Grenoble
Trials:- NCT05192980 (Principal Investigator)
Conditions: -
Chrystelle DUPRAZ, MDSeen in:
- Poitiers, Hopital jean Bernard
- Poitiers, University Hospital of Poitiers
Trials:- NCT05192980 (Principal Investigator)
- NCT04596410 (Principal Investigator)
Conditions: -
Claire BERGER, MDSeen in:
- Saint-Étienne, CHU de Saint-Etienne - Hopital Nord
- Saint-Étienne, Hopital Nord
Trials:- NCT05476939 (Principal Investigator)
- NCT05192980 (Principal Investigator)
-
Claire Briandet, MDSeen in:
- Côte d'Or, Dijon, CHU Dijon - Hôpital des Enfants
- Dijon, CHU Bocage
- Dijon, CHU Francois Mitterrand
- Dijon, DIJON CHU Hopital François Mitterand
- Dijon, DIJON Hôpital d'enfants
- Strasbourg, Service de Pédiatrie 3
Trials:- NCT05476939 (Principal Investigator)
- NCT04681417 (Principal Investigator)
- NCT02265770 (Principal Investigator)
- NCT05192980 (Principal Investigator)
- NCT02870907 (Principal Investigator)
- NCT03690570 (Principal Investigator)
-
Claire Pluchart, MDSeen in:
- Marne, Reims, CHU REIMS - American Memorial Hospital
- Reims, CHU Reims
- Reims, Chur de Reims
- Reims, Reims Chu
- Reims, University Hospital of Reims
Trials:- NCT04681417 (Principal Investigator)
- NCT02265770 (Principal Investigator)
- NCT05192980 (Principal Investigator)
- NCT04596410 (Principal Investigator)
- NCT02870907 (Principal Investigator)
-
Claudia PASQUALINI, MDSeen in:
- Villejuif, Gustave Roussy
- Villejuif, Institut Gustave ROUSSY
Trials:- NCT05192980 (Principal Investigator)
- NCT05384821 (Principal Investigator)
Conditions: -
Damien BODET, MDSeen in:
- Caen, CHU CAEN - Fédération de cancérologie - niveau 21
- Caen, CHU Caen
- Caen, Caen CHU
Trials:- NCT04681417 (Principal Investigator)
- NCT05192980 (Principal Investigator)
- NCT02870907 (Principal Investigator)
Conditions: -
Estelle THEBAUD, MDSeen in:
- Nantes, Chr Nantes
- Nantes, Chu Nantes
Trials:- NCT05192980 (Principal Investigator)
- NCT05384821 (Principal Investigator)
- NCT02870907 (Principal Investigator)
Conditions: -
Gudrun SCHLEIERMACHER, MDSeen in:
- Paris, Institut Curie
Trials:- NCT05192980 (Principal Investigator)
Conditions: -
Joy BENADIBA, MDSeen in:
- Nice, CHU Nice
- Nice, CHU de NICE - Hôpital Archet 2
Trials:- NCT05192980 (Principal Investigator)
- NCT05384821 (Principal Investigator)
Conditions: -
Julie TANDONNET, MDSeen in:
- Bordeaux, Hopital des Enfants
Trials:- NCT05192980 (Principal Investigator)
Conditions: -
Julien LEJEUNE, MDSeen in:
- Tours, Hôpital Clocheville
- Tours, University Hospital of Tours
Trials:- NCT05192980 (Principal Investigator)
- NCT04596410 (Principal Investigator)
Conditions: -
Justyna Kanold, MDSeen in:
- Clermont-Ferrand, CHU D'Estaing de CLERMONT FERRAND
- Clermont-Ferrand, CHU ESTAING Centre Régional de Cancérologie et Therapie Cellulaire Pediatrique (CRCTCP)
- Puy-de-Dôme, Clermont-Ferrand, CHU Clermont- Ferrand - Hôpital Estaing
Trials:- NCT04681417 (Principal Investigator)
- NCT02265770 (Principal Investigator)
- NCT05192980 (Principal Investigator)
-
Liana CARAUSU, MDSeen in:
- Brest, CHRU Brest
- Brest, CHRU de Brest - Hôpital Morvan
- Brest, Chu de Brest Morvan
Trials:- NCT05476939 (Principal Investigator)
- NCT05180825 (Principal Investigator)
- NCT05192980 (Principal Investigator)
-
Ludovic MANSUY, MDSeen in:
- Vandoeuvre Les Nancy, Chu Nancy
- Vandoeuvre Les Nancy, Nancy CHU
- Vandœuvre-lès-Nancy, CHRU NANCY - Hôpital d'Enfants
- Vandœuvre-lès-Nancy, CHU NANCY- Hôpital d'Enfants
Trials:- NCT04681417 (Principal Investigator)
- NCT05192980 (Principal Investigator)
- NCT05384821 (Principal Investigator)
- NCT02870907 (Principal Investigator)
Conditions: -
Marion GAMBART, MDSeen in:
- Toulouse, Hopital des Enfants
Trials:- NCT05192980 (Principal Investigator)
Conditions: -
Sarah JANNIER, MDSeen in:
- Strasbourg, CHRU STRASBOURG - Hôpital de Hautepierre
- Strasbourg, Hôpital Hautepierre-CHU Strasbourg
- Strasbourg, Service Pédiatrie Onco-hématologie - Pédiatrie III - CHU de Strasbourg - France
Trials:- NCT05640960 (Principal Investigator)
- NCT05192980 (Principal Investigator)
- NCT05384821 (Principal Investigator)
Conditions: -
Sophie TAQUE, MDSeen in:
- Rennes, CHU Hôpital Sud
Trials:- NCT05192980 (Principal Investigator)
Conditions: -
Stéphanie PROUST, MDSeen in:
- Angers, Chu Angers
Trials:- NCT05192980 (Principal Investigator)
Conditions: -
Tasnime AKBARALY, MDSeen in:
- Montpellier, Hopital Arnaud de Villeneuve
Trials:- NCT05192980 (Principal Investigator)
Conditions: -
Véronique Laithier, MDSeen in:
- Besancon, CHU de Besançon
- Besancon, Hopital Jean Minioz
- Besançon, CHU Besançon - Hôpital Jean Minjoz
- Besançon, Hopital Jean Minjoz
- Doubs, Besançon, CHRU BESANCON - Hôpital Jean Minjoz
Trials:- NCT05476939 (Principal Investigator)
- NCT05180825 (Principal Investigator)
- NCT02265770 (Principal Investigator)
- NCT05192980 (Principal Investigator)
- NCT02870907 (Principal Investigator)
Clinical Trials on Ganglioneuroblastoma
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingNeuroblastoma | Ganglioneuroblastoma, NodularUnited States, Australia, Canada, New Zealand
-
Federal Research Institute of Pediatric Hematology...RecruitingNeuroblastoma | GanglioneuroblastomaRussian Federation
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingNeuroblastoma | GanglioneuroblastomaUnited States, Canada, Puerto Rico
-
Massachusetts General HospitalNational Cancer Institute (NCI)RecruitingNeuroblastoma | GanglioneuroblastomaUnited States
-
Institut CurieRecruitingNeuroblastoma | Ganglioneuroblastoma | GanglioneuromaFrance
-
National Cancer Institute (NCI)Active, not recruitingGanglioneuroblastoma | High Risk NeuroblastomaUnited States, New Zealand, Australia
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingNeuroblastoma | Ganglioneuroblastoma | GanglioneuromaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingNeuroblastoma | Localized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | GanglioneuroblastomaUnited States, Canada, Saudi Arabia, Puerto Rico, Australia, New Zealand
-
National Cancer Institute (NCI)RecruitingNeuroblastoma | GanglioneuroblastomaUnited States
-
Federal Research Institute of Pediatric Hematology...University Medical Center Corporate Fund AstanaRecruitingNeuroblastoma | Ganglioneuroblastoma | GanglioneuromaRussian Federation